The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies

ConclusionsDespite the fact that different PCD patients were included, the assessment of the HLC‐immunoassay in MGUS, SMM, MM, and WM, our comparison with standard mp‐assays, and relevant PFS differences may excite future applications, which should be confirmed in prospective multicenter trials.

Source: European Journal of Haematology - October 5, 2017 Category: Hematology Authors: Christine Greil, Gabriele Ihorst, Felix Gaiser, Ulrich Salzer, Emanuel Bisse, Efstathios Kastritis, Heinz Ludwig, Ralph W äsch, Monika Engelhardt Tags: ORIGINAL ARTICLE Source Type: research